Compare stocks

Coloplast A/S is a Danish company specializing in the development and manufacturing of medical devices and services. Its core business operates within the healthcare industry, focusing on products for ostomy care, continence care, wound and skin care, and urology. Founded in 1957, the company has a significant history of innovation in personalized healthcare products. Headquartered in Humlebæk, Denmark, Coloplast serves a global market, ensuring strong geographic diversification. The company is strategically positioned with strengths in customer-centric product development and a robust distribution network, enhancing its competitive advantage in the medical devices sector.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.